Goldman Sachs Group Inc Royalty Pharma PLC Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 470,419 shares of RPRX stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
470,419
Previous 319,182 47.38%
Holding current value
$11.4 Million
Previous $8.42 Million 58.13%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$25.63 - $29.27 $3.88 Million - $4.43 Million
151,237 Added 47.38%
470,419 $13.3 Million
Q2 2024

Aug 13, 2024
SELL
$26.26 - $29.9 $7.45 Million - $8.49 Million
-283,806 Reduced 47.07%
319,182 $8.42 Million
Q1 2024

May 15, 2024
SELL
$27.46 - $31.33 $62.2 Million - $71 Million
-2,266,558 Reduced 78.99%
602,988 $18.3 Million
Q4 2023

Feb 13, 2024
SELL
$26.21 - $29.22 $35.1 Million - $39.2 Million
-1,340,649 Reduced 31.84%
2,869,546 $80.6 Million
Q3 2023

May 14, 2024
BUY
$26.26 - $31.38 $35.2 Million - $42.1 Million
1,340,649 Added 46.72%
4,210,195 $114 Million
Q3 2023

Nov 14, 2023
BUY
$26.26 - $31.38 $14.8 Million - $17.7 Million
563,139 Added 15.44%
4,210,195 $114 Million
Q2 2023

May 14, 2024
BUY
$29.6 - $36.56 $39.8 Million - $49.1 Million
1,343,711 Added 58.34%
3,647,056 $112 Million
Q2 2023

Aug 14, 2023
BUY
$29.6 - $36.56 $39.8 Million - $49.1 Million
1,343,711 Added 58.34%
3,647,056 $112 Million
Q1 2023

May 14, 2024
BUY
$32.77 - $39.4 $35.5 Million - $42.6 Million
1,081,886 Added 88.57%
2,303,345 $83 Million
Q1 2023

May 11, 2023
BUY
$32.77 - $39.4 $35.5 Million - $42.6 Million
1,081,886 Added 88.57%
2,303,345 $83 Million
Q4 2022

May 14, 2024
SELL
$39.17 - $44.04 $6.08 Million - $6.84 Million
-155,246 Reduced 11.28%
1,221,459 $48.3 Million
Q4 2022

Feb 13, 2023
SELL
$39.17 - $44.04 $6.08 Million - $6.84 Million
-155,246 Reduced 11.28%
1,221,459 $48.3 Million
Q3 2022

May 14, 2024
BUY
$39.88 - $44.65 $15.6 Million - $17.4 Million
390,178 Added 39.55%
1,376,705 $55.3 Million
Q3 2022

Nov 10, 2022
BUY
$39.88 - $44.65 $15.6 Million - $17.4 Million
390,178 Added 39.55%
1,376,705 $55.3 Million
Q2 2022

May 14, 2024
SELL
$37.53 - $44.22 $70.7 Million - $83.3 Million
-1,883,019 Reduced 65.62%
986,527 $41.5 Million
Q2 2022

Aug 15, 2022
SELL
$37.53 - $44.22 $15.1 Million - $17.7 Million
-401,103 Reduced 28.91%
986,527 $41.5 Million
Q1 2022

May 16, 2022
BUY
$37.46 - $42.44 $3.08 Million - $3.48 Million
82,110 Added 6.29%
1,387,630 $54.1 Million
Q4 2021

Feb 14, 2022
BUY
$35.17 - $42.48 $14.4 Million - $17.3 Million
408,117 Added 45.48%
1,305,520 $52 Million
Q3 2021

Nov 10, 2021
BUY
$36.14 - $42.24 $32.4 Million - $37.9 Million
897,403 New
897,403 $32.4 Million

Others Institutions Holding RPRX

# of Institutions
413
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email